Abstracts

“MICRO-INFECTION” OF HBV CAN OCCUR IN MSM WITH VACCINATION OR TENOFOVIR-BASED PrEP

Background: HBV vaccination and tenofovir-based PrEP prevent acute HBV hepatitis. However, there is little data on prophylactic effect of these HBV prophylaxes against asymptomatic HBV infection. We investigated acute HBV infection and its serological characteristics according to the HBV prophylaxes among an HIV-negative MSM cohort, at sexual health clinic (SHC) in Tokyo, Japan. Methods: HIV-negative…

OMICRON SPIKE ENDOWS SARS-CoV-2 WITH ENHANCED INFECTIVITY IN NASAL EPITHELIA

Background: Omicron lineages, including BA.1 and BA.2, emerged following mass COVID-19 vaccination campaigns, displaced previous SARS-CoV-2 variants of concern worldwide, and gave rise to sublineages that continue to spread among humans. Previous research has shown that Omicron lineages exhibit a decreased propensity for lower respiratory tract (lung) infection compared to ancestral SARS-CoV-2, which may explain…

EFFICACY AND COMPLEMENTARITY OF HIV-1 SUPPRESSION BY CD4-BINDING bNAbs

Background: Broadly neutralizing antibodies (bNAbs) show potential as complementary immunotherapy to combination anti-retroviral therapies for HIV-1 treatment yet infusion of a single bNAb selects for resistant variants. We developed an ex vivo assay that predicts bNAbs potential to achieve in vivo virologic response in people with HIV and allows investigation of viral resistance signatures. Methods:…

TSCM/TCM-ENRICHED ANTI-HIV duoCAR-T CELLS EXERT POTENT HIV CONTROL

Background: Anti-HIV chimeric antigen receptor (CAR) T cell therapies are candidates to functionally cure HIV infection in people with HIV (PWH). Translating such therapeutic candidates successfully into PWH will require anti-HIV CAR-T cells to persist long term and eliminate reactivated HIV-infected cells. Interestingly, recent clinical studies have shown a positive correlation between the early-memory phenotype…

PrEP CONTINUATION AMONG PERI-CONCEPTION, PREGNANT, AND LACTATING WOMEN IN KENYA

Background: Pregnant and breastfeeding persons living in high HIV prevalence settings are a priority population for oral pre-exposure prophylaxis (PrEP) for HIV prevention, due to disproportionally high risk of HIV acquisition during pregnancy and postpartum periods. Data are limited on PrEP use during peri-conception, pregnancy, and breastfeeding periods. Methods: Data are from the Partners Scale-Up…

A NATIONWIDE OPTIMIZATION STRATEGY USING SECOND GENERATION InSTIS IN MEXICO

Background: In Mexico until 2018, first line antiretroviral therapy (ART) was mainly based on either efavirenz-containing regimens (despite reports of high pre-treatment resistance levels); or on other regimens with drugs no longer considered optimal -protease inhibitors (PIs), nevirapine, maraviroc and first-generation integrase inhibitors (InSTIs)- all of them amenable to be switched to 2nd generation INSTIs…